Vimarsana
Biggest News Aggregation in the World

Page 16 - Eu Press News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eu Press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eu Press Today - Breaking & Trending Today

Biogen Appoints Monish Patolawala to its Board of Directors - Vimarsana News

Biogen Appoints Monish Patolawala to its Board of Directors

Accomplished executive brings deep expertise leading global financial organizations and overseeing successful business transformationCAMBRIDGE, Mass., Nov. 06, 2023 -- Biogen Inc. today announced...

Kojamo Plc: Kojamo plc Interim Report 1 January–30 September 2023 -November 02, 2023 at 02:01 am EDT - Vimarsana News

Kojamo Plc: Kojamo plc Interim Report 1 January–30 September 2023 -November 02, 2023 at 02:01 am EDT

Kojamo plc Stock Exchange Release, 2 November 2023 at 8.00 a.m. EET Kojamo plc Interim Report 1 January–30 September 2023 Total revenue and net rental income increased, occupancy rate improved ...

Correction - Harvia Oyj Interim Report January - September 2023 webcast on 2 November 2023 at 11:00 EET -October 26, 2023 at 02:45 am EDT - Vimarsana News

Correction - Harvia Oyj Interim Report January - September 2023 webcast on 2 November 2023 at 11:00 EET -October 26, 2023 at 02:45 am EDT

Harvia Plc press release 26 October 2023 at 9:45 a.m. EEST Correction: Harvia will hold a webcast for analysts, investors and media on 2 November 2023 at 11:00 a.m. EET. Harvia will...

Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750's Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders -October 25, 2023 at 08:00 am EDT - Vimarsana News

Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750's Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders -October 25, 2023 at 08:00 am EDT

- Preclinical data demonstrated significant activity at low doses of ORX750 in highly predictive translational models of Narcolepsy Type 1 - ORX750 advancing in IND-enabling studies; Clinical proof...

Correction: Repurchase of own shares on 23.10.2023 -October 24, 2023 at 03:30 am EDT - Vimarsana News

Correction: Repurchase of own shares on 23.10.2023 -October 24, 2023 at 03:30 am EDT

Nokia CorporationStock Exchange Release24 October 2023 at 10:30 EEST Correction: Repurchase of own shares on 23.10.2023 Correction to Nokia Oyj’s stock exchange release regarding repurchase of own...